课题基金 / 基金详情

Phase I Trial of Adenoviral Vector Delivery of the Human Inteleukin-12 cDNA b...

Phase I Trial of Adenoviral Vector Delivery of the Human Inteleukin-12 cDNA b...
人类 Inteleukin-12 cDNA 腺病毒载体递送的 I 期试验
批准号：
7044859
负责人：
MAX W SUNG
金额：
$4.58万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
项目状态：
已结题
起止时间：
2004-03-01 至 2005-02-28
来源：
https://reporter.nih.gov/project-details/7044859
关键词：
AdenoviridaeT cell receptorclinical researchclinical trial phase Icolorectal neoplasmscombination cancer therapycomplementary DNAgene delivery systemgene expressiongene therapyhuman subjecthuman therapy evaluationinterleukin 12monoclonal antibodyneoplasm /cancer immunotherapytransfection /expression vector

项目成果

MAX W SUNG的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA IN M
CLINICAL TRIAL: ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA IN M
TRIAL OF HUMAN INTERLEUKIN-12 CDNA IN METASTATIC COLORECTAL CANCER TO THE LIVER
PHASE I TRIAL OF ADENOVIRAL VECTOR DELIVERY OF THE HUMAN INTERLEUKIN-12 CDNA
海外基金